| What is flow cytometry? |
|
Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointestinal Endoscopy 1999; 50(1):23-6. |
|
Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RJ, Witzig TE, Rabinovitch PS. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993; 14(5):486-91. |
|
Bergers E, Montironi R, van Diest PJ, Prete E, Baak JP. Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases [see comments]. Human Pathology 1996; 27(6):553-60. |
|
Coon JS, Paxton H, Lucy L, Homburger H. Interlaboratory variation in DNA flow cytometry. Results of the College of American Pathologists' Survey. Archives Of Pathology And Laboratory Medicine 1994; 118(7):681-5. |
|
Fennerty MB, Sampliner RE, Way D, Riddell R, Steinbronn K, Garewal HS. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989; 97(4):815-20. |
|
Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proceedings of the National Academy of Sciences of the United States of America 1996; 93(14):7081-4. |
|
Gimenez A, Minguela A, Parrilla P, Bermejo J, Perez D, Molina J, Garcia AM, Ortiz MA, Alvarez R, de Haro LM. Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with Barrett's esophagus. Cancer 1998; 83(4):641-51. |
|
Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.Report of the DNA Cytometry Consensus Conference. Cytometry 1993; 14(5):482-5. |
|
Melville DM, Jass JR, Shepherd NA, Northover JM, Capellaro D, Richman PI, Lennard-Jones JE, Ritchie JK, Andersen SN. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations [see comments]. Gastroenterology 1988; 95(3):668-75. |
|
Menke-Pluymers MB, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994; 35(10):1348-51. |
|
Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. The American Journal of Gastroenterology 2001; 96(11):3071-83.. |
|
Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102(4 Pt 1):1212-9. |
|
Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987; 93(1):1-11. |
|
Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Human Pathology 1988; 19(2):166-78. |
|
Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. American Journal of Gastroenterology 2000; 95(7):1669-76. |
|
Robaszkiewicz M, Hardy E, Volant A, Nousbaum JB, Cauvin JM, Calament G, Robert FX, Saleun JP, Gouerou H. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases]. Gastroenterol Clin Biol 1991; 15(10):703-10. |
|
Sagan C, Flejou JF, Diebold MD, Potet F, Le Bodic MF. [Reproducibility of histological criteria of dysplasia in Barrett mucosa]. Gastroenterol Clin Biol 1994; 18(1):D31-4. |
|
Sen S. Aneuploidy and Cancer. Current Opinion in Oncology 2000; 12:82-88. |
|
Shankey TV, Kallioniemi OP, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 1993; 14(5):497-500. |
|
Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L, Cox C. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology [published erratum appears in Cytometry 1993 Oct;14(7):842]. Cytometry 1993; 14(5):472-7. |
|
Teodori L, Gohde W, Persiani M, Ferrario F, Tirindelli Danesi D, Scarpignato C, Di Tondo U, Alo P, Capurso L. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry 1998; 34(6):257-63. |
|
Tirindelli Danesi DR, Spano M, Altavista P, Pantarotto M, Filippini C, Mazzini G, Erba E, Ubezio P. Quality Control Study of the Italian Group of Cytometry on Flow Cytometry DNA content Measurements:II. Factors Affecting Inter- and Intralaboratory Variability. Cytometry 1997; 30: 85-97. |
|
van Sandick JW, Baak JP, van Lanschot JJ, Polkowski W, ten Kate FJ, Obertop H, Offerhaus GJ. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J Pathol 2000; 190(2):177-183. |
|
Wheeless LL, Badalament RA, de Vere White RW, Fradet Y, Tribukait B. Consensus review of the clinical utility of DNA cytometry in bladder cancer.Report of the DNA Cytometry Consensus Conference. Cytometry 1993; 14(5):478-81. |
|
